News | July 19, 2024
Zydus signs patent licensing agreement with Takeda for 'VaultA’ in India
The pooled prevalence of GERD in the Indian population is 15.6 %
The pooled prevalence of GERD in the Indian population is 15.6 %
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The Unit has been issued GMP Certification from ANVISA-Brazil
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Imfinzi also recommended for patients with mismatch repair deficient disease
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Subscribe To Our Newsletter & Stay Updated
